Assessing and Managing Opiate-Induced Constipation in Adults with Cancer

Bruera E. , Suarez-Almazor M. , Velasco A. The assessment of constipation in terminal cancer patients admitted to a palliative care unit: a retrospective review. J Pain Symptom Manage. 1994; 9: 515–519.

McMillan S.C. , Tittle M. A descriptive study of the management of pain and pain-related side effects in a cancer center and a hospice. Hosp J. 1995; 10: 89–108.

Tittle M. , McMillan S.C. Pain and pain-related side effects in an ICU and on a surgical unit: nurses’ management. Am J Crit Care. 1994; 3: 25–30.

McMillan S.C. , Williams F.A. Validity and reliability of the Constipation Assessment Scale. Cancer Nurs. 1989; 12: 183–188.

Addington-Hall J.M. , MacDonald L.D. , Anderson H.R. Dying from cancer: the views of the bereaved family and friends about the experiences of terminally ill patients. Palliat Med. 1991; 5: 207–214.

Walsh T.D. Oral morphine in chronic cancer pain. Pain. 1984; 18: 1–11.

Vainio A. , Auvinen A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. J Pain Symptom Manage. 1996; 12: 3–10.

Donnelly S. , Walsh D. , Rybicki L. The symptoms of advanced cancer: identification of clinical and research priorities by assessment of prevalence and severity. J Palliat Care. 1995; 11: 27–32.

Weitzner M.A. , Moody L.N. , McMillan S.C. Symptom management issues in hospice care. Am J Hosp Palliat Care. 1997; 14: 190–195.

McMillan S.C. Presence and severity of constipation in hospice patients with advanced cancer. Am J Hosp Palliat Care. 2002; 19: 426–430.

McMillan S.C. , Weitzner M. How problematic are various aspects of quality of life in patients with cancer at the end of life. Oncol Nurs Forum. 2000; 27: 817–823.

McMillan S.C. , Small B.J. Symptom distress and quality of life in patients with cancer newly admitted to hospice homecare. Oncol Nurs Forum. 2002; 29: 1421–1428.

Connell A.M. , Hilton C. , Irvin E.G. Variation in bowel habits in two population samples. Br Med J. 1965; 2: 1095–1099.

McShane R.E. , McLane A.M. Constipation: consensual and empirical validation. Nurs Clin North Am. 1985; 20: 801–808.

Cimprich B. Symptom management: constipation. Cancer Nurs. 1985; 8: 39–43.

Kavanagh J.J. , Copeland L.J. , Gershenson D.M. Continuousinfusion vinblastine in refractory carcinoma of the cervix: a phase II trial. Gynecol Oncol. 1985; 21: 211–214.

Hinrichs M. , Huseboe J. , Tang J.H. Research-based protocol. Management of constipation. J Gerontol Nurs. 2001; 27: 17–28.

Snapes W.J. Therapy in patients with constipation. Home HealthCare Consult. 1996; 3: 4–17.

Maguire L.C. , Yon J.L. , Miller E. Prevention of narcotic-induced constipation. N Engl J Med. 1981; 305: 1651.

Adler H.F. , Atkinson A.J. , Ivy A.C. Effect of morphine and dilaudid on the ileum and of morphine, dilaudid, and atropine on the colon of man. Arch Intern Med. 1942; 69: 974–985.

Fallon M. , O'Neill B. ABC of palliative care. Constipation and diarrhoea. Br Med J. 1997; 315: 1293–1296.

McMillan S.C. , Tittle M. , Hagan S. Management of pain and pain-related symptoms in hospitalized veterans with cancer. Cancer Nurs. 2000; 23: 327–336.

Broussard B.S. The constipation assessment scale for pregnancy. J Obstet Gynecol Neonatal Nurs. 1998; 27: 297–301.

Cheskin L.J. , Kamal N. , Crowell M.D. Mechanisms of constipation in older persons and effects of fiber compared with placebo. J Am Geriatr Soc. 1995; 43: 666–669.

Hanlon M. Patients with constipation requiring a bowel management program. J Wound Ostomy Continence Nurs. 1997; 24: 325–329.

Karam S.E. , Nies D.M. Student/staff collaboration: a pilot bowel management program. J Gerontol Nurs. 1994; 20: 32–40.

Geders J.M. , Gaing A. , Bauman W.A. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. Am J Gastroenterol. 1995; 90: 285–289.

Corcoran M.B. Polypharmacy in the older patient with cancer. Cancer Control. 1997; 4: 419–428.

Kleessen B. , Sykura B. , Zunft H.J. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr. 1997; 65: 1397–1402.

Cleveland MV. , Flavin D.P. , Ruben R.A. New polyethylene glycol laxative for treatment of constipation in adults: a randomized, double-blind, placebo-controlled study. South Med J. 2001; 94: 478–481.

Agra Y. , Sacristan A. , Gonzalez M. Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. J Pain Symptom Manage. 1998; 15: 1–7.

Soffer E.E. , Metcalf A. , Launspach J. Misoprostol is effective treatment for patients with severe chronic constipation. Dig Dis Sci. 1994; 39: 929–933.

Verne G.N. , Eaker E.Y. , Davis R.H. Colchicine is an effective treatment for patients with chronic constipation: an open-label trial. Dig Dis Sci. 1997; 42: 1959–1963.

Culpepper-Morgan J.A. , Inturrisi C.E. , Portenoy R.K. Treatment of opioid-induced constipation with oral naloxone: a pilot study. Clin Pharmacol Ther. 1992; 52: 90–95.

Yuan C.S. , Foss J.F. , Osinski J. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time. Clin Pharmacol Ther. 1997; 61: 467–475.

Sykes N.P. An investigation of the ability of oral naloxone to correct opioid-related constipation in patients with advanced cancer. Palliat Med. 1996; 10: 135–144.

Yuan C.S. Clinical status of methylnaltrexone: a new agent to prevent and manage opioid-induced side effects. J Support Oncol. 2004; 2: 111–122.

Walsh D. Commentary on research in cancer pain and palliative care: assessment and treatment of opioid-induced constipation. Cancer Pain Release. 1998; 11: 6–7.